Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting

Pilot and Feasibility Study of Hematopoietic Stem Cell Gene Transfer for the Wiskott-Aldrich Syndrome

This study is currently recruiting participants. (see Contacts and Locations)
Verified November 2016 by Boston Children’s Hospital
Sponsor:
Information provided by (Responsible Party):
David Williams, Boston Children's Hospital
ClinicalTrials.gov Identifier:
NCT01410825
First received: August 4, 2011
Last updated: November 7, 2016
Last verified: November 2016
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study is currently recruiting participants.
  Estimated Study Completion Date: July 2031
  Estimated Primary Completion Date: April 2017 (Final data collection date for primary outcome measure)